78 related articles for article (PubMed ID: 25200207)
21. FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1.
Kwon M; Rubio G; Nolan N; Auteri P; Volmar JA; Adem A; Javidian P; Zhou Z; Verzi MP; Pine SR; Libutti SK
Cancer Res; 2021 Nov; 81(21):5523-5539. PubMed ID: 34417201
[TBL] [Abstract][Full Text] [Related]
22. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
23. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
24. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
Cai C; Zhu X
Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
[TBL] [Abstract][Full Text] [Related]
25. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
26. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
27. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
28. Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells.
Laezza C; D'Alessandro A; Paladino S; Maria Malfitano A; Chiara Proto M; Gazzerro P; Pisanti S; Santoro A; Ciaglia E; Bifulco M;
Eur J Cancer; 2012 Nov; 48(16):3112-22. PubMed ID: 22425263
[TBL] [Abstract][Full Text] [Related]
29. The Wnt/β-catenin pathway in ovarian cancer: a review.
Arend RC; Londoño-Joshi AI; Straughn JM; Buchsbaum DJ
Gynecol Oncol; 2013 Dec; 131(3):772-9. PubMed ID: 24125749
[TBL] [Abstract][Full Text] [Related]
30. Destruxin B inhibits hepatocellular carcinoma cell growth through modulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Huynh TT; Rao YK; Lee WH; Chen HA; Le TD; Tzeng DT; Wang LS; Wu AT; Lin YF; Tzeng YM; Yeh CT
Toxicol In Vitro; 2014 Jun; 28(4):552-61. PubMed ID: 24434019
[TBL] [Abstract][Full Text] [Related]
31. Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer.
Wang Z; Ma Q
Med Hypotheses; 2007; 69(4):816-20. PubMed ID: 17379424
[TBL] [Abstract][Full Text] [Related]
32. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
Ginnebaugh KR; Ahmad A; Sarkar FH
Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
35. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
[TBL] [Abstract][Full Text] [Related]
36. Apicidin-resistant HA22T hepatocellular carcinoma cells strongly activated the Wnt/β-catenin signaling pathway and MMP-2 expression via the IGF-IR/PI3K/Akt signaling pathway enhancing cell metastatic effect.
Hsieh CH; Cheng LH; Hsu HH; Ho TJ; Tu CC; Lin YM; Chen MC; Tsai FJ; Hsieh YL; Huang CY
Biosci Biotechnol Biochem; 2013; 77(12):2397-404. PubMed ID: 24317053
[TBL] [Abstract][Full Text] [Related]
37. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
[TBL] [Abstract][Full Text] [Related]
38. Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy.
Eyvazi S; Kazemi B; Dastmalchi S; Bandehpour M
Curr Cancer Drug Targets; 2018; 18(4):328-336. PubMed ID: 28820056
[TBL] [Abstract][Full Text] [Related]
39. Post-translational modification of the death receptor complex as a potential therapeutic target in cancer.
Kang K; Lee SR; Piao X; Hur GM
Arch Pharm Res; 2019 Jan; 42(1):76-87. PubMed ID: 30610617
[TBL] [Abstract][Full Text] [Related]
40. Targeting epithelial-to-mesenchymal transition for cancer therapy.
Wang Z
Curr Pharm Des; 2015; 21(10):1239. PubMed ID: 25658676
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]